Sodium deoxyribonucleate for reducing acute bladder toxicity during radiotherapy in patients with endometrial cancer: a pilot randomized controlled study
Pharmateca · 09.10.2026 · 6_2026 · 74-82
DOI: 10.18565/pharmateca.2026.6.74-82 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmateca, erschienen am 09.10.2026. Verfasst von Ivashin A.A. Ivashin und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ivashin, I. A., Skopin, S. P., Deryabina, D. O., & Piskunova, P. A. (2026). Sodium deoxyribonucleate for reducing acute bladder toxicity during radiotherapy in patients with endometrial cancer: a pilot randomized controlled study. Pharmateca, 6_2026, 74-82. https://doi.org/10.18565/pharmateca.2026.6.74-82
Vancouver
Ivashin IA, Skopin SP, Deryabina DO, Piskunova PA. Sodium deoxyribonucleate for reducing acute bladder toxicity during radiotherapy in patients with endometrial cancer: a pilot randomized controlled study. Pharmateca. 2026;6_2026:74-82. doi:10.18565/pharmateca.2026.6.74-82
BibTeX
@article{Ivashin2026,
author = {Ivashin, Ivashin A.A. and Skopin, Skopin P.I. and Deryabina, Deryabina O.N. and Piskunova, Piskunova A.V.},
title = {Sodium deoxyribonucleate for reducing acute bladder toxicity during radiotherapy in patients with endometrial cancer: a pilot randomized controlled study},
journal = {Pharmateca},
year = {2026},
volume = {6_2026},
pages = {74--82},
doi = {10.18565/pharmateca.2026.6.74-82}
}
EUVIMED